Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(0.83) by 4.82 percent. This is a 11.24 percent increase over losses of $(0.89) per share from the same period last year.
Occidental Petroleum Inks $1.1B Acquisition Deal To Accelerate Net-Zero Strategy
Occidental Petroleum Corp (NYSE: OXY) inked a definitive deal to acquire all the outstanding equity of Carbon Engineering Ltd.
